Esperion Therapeutics
ESPR
#6169
Rank
C$1.23 B
Marketcap
C$5.21
Share price
-1.58%
Change (1 day)
11.18%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): C-$0.76

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.75. In 2024 the company made an earnings per share (EPS) of C-$0.32 an increase over its 2023 EPS that were of C-$2.96.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.76138.1%
2024C-$0.32-89.15%
2023C-$2.96-40.28%
2022C-$4.96-62.87%
2021C-$13.3580.38%
2020C-$7.4050.14%
2019C-$4.93-53.18%
2018C-$10.537.41%
2017C-$9.80110.81%
2016C-$4.6547.35%
2015C-$3.150.89%
2014C-$3.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
C-$8.29 1,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$3.80-603.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.40-418.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$60.64-8,144.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.15-79.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C-$0.27-64.81%๐Ÿ‡บ๐Ÿ‡ธ USA